Company Filing History:
Years Active: 2017-2019
Title: Venkata Srinivasa Rao Velivela: Innovator in Pharmaceutical Processes
Introduction
Venkata Srinivasa Rao Velivela is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important medicinal compounds. With a total of five patents to his name, Velivela's work has had a considerable impact on the industry.
Latest Patents
One of his latest patents is titled "Process for the preparation of Linezolid." This invention relates to an improved method for preparing Linezolid, specifically focusing on the synthesis of (S)–N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] phthalimide and (S)-glycidyl phthalimide intermediates. These intermediates are crucial for the preparation of Linezolid, a vital antibiotic. Another significant patent is "Process for the preparation of Canagliflozin," which provides a novel method for synthesizing Canagliflozin and its hydrates using innovative intermediates. This process is not only novel but also commercially and industrially applicable.
Career Highlights
Throughout his career, Velivela has worked with various companies, including Optimus Drugs Private Limited and Optimus Drugs (P) Limited. His experience in these organizations has allowed him to refine his skills and contribute to the development of pharmaceutical processes that are both efficient and effective.
Collaborations
Some of his notable coworkers include Srinivas Reddy Desi Reddy and Dnyandev Ragho Rane. Their collaboration has likely fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical processes.
Conclusion
Venkata Srinivasa Rao Velivela is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in the field. His contributions, particularly in the preparation of Linezolid and Canagliflozin, demonstrate his commitment to innovation and excellence in the pharmaceutical industry.